Related Experiment Videos
Intracellular immunization with cytosolic recombinant antibodies
S Biocca1, P Pierandrei-Amaldi, N Campioni
1Institute of Neurobiology, CNR, Roma, Italy.
Bio/Technology (Nature Publishing Company)
|April 1, 1994
Summary
Researchers developed a method to inactivate cellular proteins using intracellular antibody expression. This strategy successfully inhibited p21 protein function and blocked meiotic maturation in Xenopus oocytes.
Area of Science:
- Molecular Biology
- Cell Biology
- Immunology
Background:
- Cellular protein function is crucial for biological processes.
- Targeting specific proteins is key to understanding cellular mechanisms.
- Intracellular protein inactivation offers a novel research approach.
Purpose of the Study:
- To develop a strategy for inactivating cellular proteins via intracellular antibody expression.
- To investigate the inhibition of p21 protein function using recombinant antibodies.
- To assess the impact of intracellular antibody expression on oocyte meiotic maturation.
Main Methods:
- Cloning variable regions of anti-p21ras monoclonal antibody Y13-259 into expression vectors.
- Engineering recombinant antibodies (whole molecule or single-chain Fv fragment) for cytosolic expression by mutating or deleting leader sequences.
- Expressing recombinant antibodies in Xenopus laevis oocytes and analyzing their localization and functional effects on H1 kinase activity and meiotic maturation.
Main Results:
- Recombinant antibodies expressed in the cytosol colocalized with endogenous p21ras protein at the oocyte plasma membrane.
- Intracellularly expressed anti-p21ras antibodies significantly inhibited insulin-induced H1 kinase activity.
- Cytosolic anti-p21ras single-chain Fv fragments effectively blocked meiotic maturation in oocytes.
Conclusions:
- Intracellular expression of immunoglobulin genes provides a viable strategy for cellular protein inactivation in vertebrate cells.
- This approach allows for targeted inhibition of specific proteins like p21ras.
- The method demonstrates the potential to block biological functions by interfering with protein activity through engineered antibodies.